Report Detail

Table of Content

    1 Market Overview

    • 1.1 Market Segment Overview
      • 1.1.1 Product Definition
      • 1.1.2 Market by Type
        • 1.1.2.1 Existing Drugs
        • 1.1.2.2 Akynzeo (Netupitant-Palonosetron FDC)
        • 1.1.2.3 Aloxi (Palonosetron)
        • 1.1.2.4 Emend (Aprepitant)
        • 1.1.2.5 Kytril Generic (Granisetron)
        • 1.1.2.6 Zofran Generic (Ondansetron)
        • 1.1.2.7 Pipeline Drugs
        • 1.1.2.8 SUSTOL (Granisetron Injection extended release)
        • 1.1.2.9 Rolapitant
      • 1.1.3 Market by Application
        • 1.1.3.1 Serotonin Receptor Antagonists
        • 1.1.3.2 NK1 Receptor Antagonists
    • 1.2 Global and China Market Size
      • 1.2.1 Global Overview
      • 1.2.2 China Overview

    2 Global and China Market by Company

    • 2.1 Global
      • 2.1.1 Global Sales by Company
      • 2.1.2 Global Price by Company
    • 2.2 China
      • 2.2.1 China Sales by Company
      • 2.2.2 China Price by Company

    3 Global and China Market by Type

    • 3.1 Global
      • 3.1.1 Global Sales by Type
      • 3.1.2 Global Price by Type
    • 3.2 China
      • 3.2.1 China Sales by Type
      • 3.2.2 China Price by Type

    4 Global and China Market by Application

    • 4.1 Global
      • 4.1.1 Global Sales by Application
      • 4.1.2 Global Price by Application
    • 4.2 China
      • 4.2.1 China Sales by Application
      • 4.2.2 China Price by Application

    5 China Trade

    • 5.1 Export
    • 5.2 Import

    6 Key Manufacturers

    • 6.1 Merck & Co., Inc.
      • 6.1.1 Company Information
      • 6.1.2 Product Specifications
      • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.2 GlaxoSmithKline plc
    • 6.3 Tesaro, Inc.
    • 6.4 Helsinn Group
    • 6.5 F. Hoffmann-La Roche Ltd.
    • 6.6 Heron Therapeutics, Inc.
    • 6.7 Dr. Reddy's Laboratories Ltd.
    • 6.8 Acacia Pharma
    • 6.9 Sun Pharmaceutical Industry Ltd.
    • 6.10 Otsuka Holdings Co., Ltd.

    7 Industry Upstream

    • 7.1 Industry Chain
    • 7.2 Raw Materials

    8 Market Environment

    • 8.1 SWOT
    • 8.2 Porter's Five Forces

    9 Conclusion

    Summary

    Market Segment as follows:
    By Type
    Existing Drugs
    Akynzeo (Netupitant-Palonosetron FDC)
    Aloxi (Palonosetron)
    Emend (Aprepitant)
    Kytril Generic (Granisetron)
    Zofran Generic (Ondansetron)
    Pipeline Drugs
    SUSTOL (Granisetron Injection extended release)
    Rolapitant
    By Application
    Serotonin Receptor Antagonists
    NK1 Receptor Antagonists
    By Company
    Merck & Co., Inc.
    GlaxoSmithKline plc
    Tesaro, Inc.
    Helsinn Group
    F. Hoffmann-La Roche Ltd.
    Heron Therapeutics, Inc.
    Dr. Reddy's Laboratories Ltd.
    Acacia Pharma
    Sun Pharmaceutical Industry Ltd.
    Otsuka Holdings Co., Ltd.
    The main contents of the report including:
    Section 1:
    Product definition, type and application, global and China market overview;
    Section 2:
    Global and China Market competition by company;
    Section 3:
    Global and China sales revenue, volume and price by type;
    Section 4:
    Global and China sales revenue, volume and price by application;
    Section 5:
    China export and import;
    Section 6:
    Company information, business overview, sales data and product specifications;
    Section 7:
    Industry chain and raw materials;
    Section 8:
    SWOT and Porter's Five Forces;
    Section 9:
    Conclusion.


    Summary:
    Get latest Market Research Reports on Chemotherapy-Induced Nausea and Vomiting Drugs. Industry analysis & Market Report on Chemotherapy-Induced Nausea and Vomiting Drugs is a syndicated market report, published as Global and China Chemotherapy-Induced Nausea and Vomiting Drugs Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,000.00
    $3,000.00
    $4,000.00
    1,464.01
    2,196.01
    2,928.02
    1,650.33
    2,475.50
    3,300.66
    207,544.00
    311,316.00
    415,088.00
    146,088.20
    219,132.30
    292,176.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report